期刊文献+

流式细胞术结合G418筛选重组质粒稳定转染细胞 被引量:9

Combined use of flow cytometry and G418 to screen the recombinant plasmid transfected cells
下载PDF
导出
摘要 目的:探索优化重组质粒转染细胞后的筛选方法,以得到高纯度U937转染细胞。方法:选择带Neor及GFP基因的质粒pRNATU6.1/Neo。根据流式细胞仪可分选GFP阳性细胞这一特点,在质粒转染细胞后比较单用G418筛选与合并使用流式细胞仪分选后的筛选效果。结果:单用G418筛选时最高筛选效率为72.0%;合并使用G418及流式细胞仪分选后的筛选效率均在90.0%以上。结论:合并使用G418及流式细胞仪分选是一种高效的筛选方法。 Objective To optimize the selective method to obtain the pure recombinant plasmid transfected U937 cells. Methods pRNAT U6.1/Neo plasmid containing both Neor and GEP genes was selected. After the plasmids had been transfected into U937 cells, the purity of the transfected cells, selected by G418 only or by both G418 and flow cytometer (FCM), was compared. Results The highest purity of GFP positive cells was 72.0% when selected by G418 only; however, the purity of GFP positive cells was always above 90.0% while using both G418 and FCM method. Conclusions It is a highly effective method to select the transfected cells using both G418 and FCM.
出处 《诊断学理论与实践》 2006年第1期52-55,共4页 Journal of Diagnostics Concepts & Practice
基金 国家自然科学基金资助项目(30271660)
关键词 质粒 GFP G418 流式细胞术 Plasmid GFP G418 Flow cytomety
  • 相关文献

参考文献9

二级参考文献43

  • 1[2]Scanlan MJ, Gure AO, Jungbluth AA, et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy [J]. Immunol Rev,2002,188( 1 ) :22 - 32.
  • 2[4]Coulie PG, Karanikas V, Lurquin C, et al. Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen [J]. Immunol Rev, 2002,188(1):33-42.
  • 3[5]Marchand M, Punt C J, Aamdal S, et al. Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report[J]. Eur J Cancer, 2003,39(1) :70- 77.
  • 4[6]Zhang Y, Chaux P, Stroobant V, et al. A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein[J]. J Immunol, 2003, 171(1): 219-225.
  • 5[7]Li GC, He F, Shao X, et al. Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo[J]. Cancer Res, 2003,63(12):3 268-3 274.
  • 6[9]Seliger B, Wollscheid U, Momburg F, et al. Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells[J]. Cancer Res,2001, 61(3): 1 095 -1099.
  • 7[10]Mizuno A, Mie M, Yanngida Y, et al.The secretory response through electric stimulation of differentiated PC12 rat pheochromocytoma cells transfected with neuropeptide Y fused with enhanced green fluorescent protein[ J]. Biotechnol Lett, 2003,25(7) :547 - 552.
  • 8Nixon AJ,Brower-Toland BD,Bent SJ,et al.Insulin-like growth factor-I gene therapy applications for cartilage repair.Clin Orthop,2000,379S:201-213.
  • 9Tumia NS,Johnstone AJ.Regional regenerative potential of meniscal cartilage exposed to recombinant insulin-like growth factor-I in vitro.J Bone Joint Surg Br,2004,86:1077-1081.
  • 10Fortier LA,Mohammed HO,Lust G,et al.Insulin-like growth factor-1 enhances cell-based repair of articular cartilage.J Bone Joint Surg Br,2002,84:276-288.

共引文献98

同被引文献84

引证文献9

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部